Two papers by Bonfield and coworkers [29,30] suggest that PAP patients with low GMAbs titer have less active disease and respond to subcutaneous GM-CSF with a further decline in autoantibodies. The gene discussed is CSF2; the disease is pulmonary alveolar proteinosis.